TOPOTECAN

Topotecan is a topoisomerase I inhibitor used in ovarian, cervical, and lung cancers. Side effects include myelosuppression, nausea, alopecia, and fatigue. Only GMP materials will be supplied, logistics all according to GDP.

SKU: e082db5f933a Category: Tags: ,

Product Description


Mechanism of Action

TOPOTECAN demonstrates a multilayer biochemical interaction architecture integrating highbandwidth signalling interference, catalyticdomain perturbation, mitochondrialnetwork recalibration, ionflux redistribution, cytoskeletal restructuring, membranepotential modulation and transcriptionfactor pathway realignment. Its molecular conformation enables docking to catalytic residues, allosteric nodes, transmembrane helices, nucleotidebinding pockets, redoxbuffer centres and polymeric scaffolding complexes, providing systemwide influence across metabolic, electrophysiological, structural and genomic domains.

At the signalling stratum, TOPOTECAN may reshape phosphorylation landscapes, alter the propagation kinetics of ERK, MAPK, JNK and p38 pathways, modulate PI3KAKT survival gating, adjust Gprotein coupling efficiency, redistribute Ca²⁺ microdomains, influence IP/DAG signalling geometry, and redefine cAMPPKA amplitude. Mitochondrial effects include ETCcomplex rebalancing, ATP/ADP cycle remapping, ROSthreshold displacement, membranepotential polarity modulation and crossorganelle stress signalling.

HighPrecision

  • Kinomescale cascade interference mapping & catalyticpathway reconstruction
  • Highresolution docking, ligandmetastability tracking & conformationalflow modelling
  • UPR/ERstress, mitophagy and organelle crosstalk quantification
  • Multiomics regulatorynetwork reconstruction (RNAseq, metabolomics, phosphoproteomics, proteomics)
  • Cytoskeletal mechanics including actin/tubulin turnover and forcedistribution modelling
  • Cellfate simulations across apoptosis, necroptosis, ferroptosis & parthanatos pathways
  • AIenhanced SAR/QSAR optimisation engines for predictive compound modelling

Toxicodynamics & Cellular Hazard Spectrum

  • Acute ROS surge and antioxidantbuffer saturation
  • Mitochondrial fragmentation or ETCaxis collapse
  • Severe Na⁺/K⁺/Ca²⁺ ionhomeostasis destabilisation
  • Cytoskeletal depolymerisation & structuralintegrity failure
  • Membranetension breakdown & lipidbilayer thinning
  • Hyperactivation of inflammatory master regulators (NF-κB, STAT, IRF families)
  • Activation of multiple programmed-cell-death pathways
  • Epigenetic drift including methylation and acetylation instability

For expert not intended for biological or therapeutic exposure.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C23H23N3O5

Molecular Weight

421.4 g/mol

CAS Number

123948-87-8

Storage Condition

Store the vials protected from light in the original cartons at controlled room temperature between 20 deg and 25 °C (68 deg and 77 °F).

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

topotecan; 123948-87-8; Hycamptamine; Topotecan lactone; Nogitecan

IUPAC/Chemical Name

(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

InChl Key

UCFGDBYHRUNTLO-QHCPKHFHSA-N

InChl Code

InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/60700;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download